Delivery Order SPE2DB20D9127-SPE2DB25FPRE7
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, with a period of performance through April 1, 2024, is for the delivery of the pharmaceutical product Trikafta 100-50-75 mg/150 mg. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB22D9102 with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a specialized pharmaceutical product, with an ultimate completion date of April 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,928.72 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The delivery order, which is set to be completed by July 22, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84-count units). This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $55,580.49 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under DLA's SPE2DB Pharmaceutical Prime Vendor program, is to provide the pharmaceutical product Trikafta 100-50-75 mg/150 mg with an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group holds a large, single-award indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a $51,136.76 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta 100-50-75 mg/75 mg packets, a specialized pharmaceutical product, with a performance period through June 26, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the drug Trikafta, with a completion date of February 13, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a separate indefinite delivery contract with DLA valued at up to $4,999,999 through 2025 to provide a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $18,488.12 for the pharmaceutical product Trikafta 100-50-75 mg/150 mg. The contract has a period of performance ending on February 27, 2025 and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Trikafta. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRE7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $18,488.12 on August 21, 2025. The order, valued at $18,488.12 with a firm fixed-price contract type, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84 count) to be delivered to Park Ridge, Illinois by August 22, 2025. This award was issued without a set-aside designation, enabling DMS Pharmaceutical Group to compete on an open basis despite its small business status. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.9 billion contract vehicle that runs through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts for specialized medications spanning oncology treatments, vaccines, contraceptive devices, and other prescription products essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/21/25 |